Navigation Links
RenAvast for Cats and Dogs Will Now Be Distributed In Sweden, Denmark, Norway and Finland
Date:8/26/2014

Reno, NV (PRWEB) August 26, 2014

Bio Health Solutions, the developers and manufacturers of RenAvast, a nutritional supplement to support natural kidney function in cats and dogs, has entered into a 3 year distribution agreement with VetNutra to distribute RenAvast to veterinarians in Sweden, Denmark, Norway and Finland.

RenAvast is a high quality, effective product used to support natural kidney function in cats and dogs. RenAvast is 100% safe with no reported side effects. RenAvast is a combination of naturally occurring amino acids and peptides. Cats and dogs have seen improvements within weeks of starting RenAvast. Reported improvements include but are not limited to coat improvement, increased appetite, decreased vomiting, weight gain and a general all over sense of feeling better.

Prior to entering this distribution agreement, VetNutra distributed over 100 bottles of feline Renavast to several veterinary clinics in Sweden. The veterinarians were extremely satisfied with the positive results they saw with cats which prompted VetNutra to move forward with a distribution agreement.
Bio Health Solutions is committed to developing safe, effective, high quality products to improve and extend the lives of humans and their companion animals. All products are manufactured at a FDA licensed manufacturing facility. The manuscript for the study of RenAvast is pending peer review publication. For details about the specific ingredients contact Bio Health Solutions.

Visit http://www.renavast.com and http://www.biohealthsolutions.com

Read the full story at http://www.prweb.com/releases/2014/08/prweb12120073.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Moffitt Cancer Center researchers analyze how Spanish smoking relapse booklets are distributed
2. Pwnie Express Releases Citadel PX for Distributed Penetration Testing
3. Almost Nuts! Now Being Distributed by L&L Foods
4. The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials
5. The Tenth Swedish-American Life Science Summit, takingplace in Stockholm, Sweden, August 20-22nd, will focus on The Future of Medicine
6. USD $1.15 Billion Commitment over Three Years to Help Save the Lives of Children and Women Secured through World Bank, UNICEF, USAID and Norway
7. OxBlue Continues International Expansion in Multi-Use Green Project in Norway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... ... spark a conversation on the current obstacles facing infection prevention and offer strategies ... deaths caused by these infections. , The print component of “Fighting Infection” ...
(Date:3/24/2017)... Dallas, Texas (PRWEB) , ... March 24, 2017 , ... ... Budget Office score is invalid because it does not obey the rules Congress has ... million full-time equivalent jobs, which the GOP reform would restore. Yet, it estimates a ...
(Date:3/24/2017)... Sedona, Arizona (PRWEB) , ... March 24, 2017 ... ... Shamangelic Healing Center, Sedona, Arizona’s Premier Center for Shamanic Healing and Spiritual Awakening, ... Jorge Luis Delgado, June 9--24, 2017. This sacred and spiritual journey during ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. She ... Record, The majority of cases litigated under ERISA involve claims for long-term disability ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... PUNE, India , March 24, 2017 ... conjugates market has been growing rapidly as the global sales of ... Globally, the growth in the antibody drug conjugates market is driven ... incidences of cancer and wider therapeutic window offered by ADCs. ... Browse 3 Tables and ...
(Date:3/24/2017)... 2017  GenomeDx Biosciences today announced that six abstracts ... Prostate Cancer Classifier tests will be presented at the ... Congress held March 24 to 28, 2017 in ... is Europe,s largest urological event ... urological field. The abstract titled "Muscle invasive ...
(Date:3/24/2017)... Tenn. , March 23, 2017  Provectus ... or the "Company"), a clinical-stage oncology and dermatology ... announced Definitive Financing Commitment Term Sheet (the "Definitive ... a group of the Company,s stockholders, who are ... Group" in a Form 8-K filed with the ...
Breaking Medicine Technology: